Genome-wide loss of heterozygosity analysis from laser capture microdissected prostate cancer using single nucleotide polymorphic allele (SNP) arrays and a novel bioinformatics platform dChipSNP

Cancer Research

Volumn 63, Issue 16, 2003, Pages 4781-4785

  Lieberfarb, Marshall E ^a   Lin, Ming ^d   Lechpammer, Mirna ^c   Li, Cheng ^a,d   Tanenbaum, David M ^a   Febbo, Phillip G ^a,c   Wright, Renée L ^e   Shim, Judy ^a   Kantoff, Philip W ^a,b,c   Loda, Massimo ^c   Meyerson, Matthew ^a,c   Sellers, William R ^a,b,c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e Dana Farber Cancer Institute ^*

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; BIOINFORMATICS; CHROMOSOME MICRODISSECTION; CONTROLLED STUDY; DNA MICROARRAY; FROZEN SECTION; GENE; GENE MAPPING; GENOME; GENOTYPE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; LASER CAPTURE MICRODISSECTION; PRIORITY JOURNAL; PROSTATE CANCER; PTEN GENE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

ALLELES; COMPUTATIONAL BIOLOGY; DNA, NEOPLASM; HUMANS; LOSS OF HETEROZYGOSITY; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS;

EID: 0041940140     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Knudson, A. G., Jr. Mutation and cancer: statistical study of retinoblastoma, Proc. Natl. Acad. Sci. USA, 68: 820-823, 1971.
2. Cavenee, W. K., Dryja, T. P., Phillips, R. A., Benedict, W. F., Godbout, R., Gallie, B. L., Murphree, A. L., Strong, L. C., and White, R. L. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature (Lond.), 305: 779-784, 1983.
3. Lindblad-Toh, K., Tanenbaum, D. M., Daly, M. J., Winchester, E., Lui, W. O., Villapakkam, A., Stanton, S. E., Larsson, C., Hudson, T. J., Johnson, B. E., Lander, E. S., and Meyerson, M. Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays. Nat. Biotechnol., 18: 1001-1005, 2000.
4. Schubert, E. L., Hsu, L., Cousens, L. A., Glogovac, J., Self, S., Reid, B. J., Rabinovitch, P. S., and Porter, P. L. Single nucleotide polymorphism array analysis of flow-sorted epithelial cells from frozen versus fixed tissues for whole genome analysis of allelic loss in breast cancer. Am. J. Pathol., 160: 73-79, 2002.
5. Dumur, C. I., Dechsukhum, C., Ware, J. L., Cofield, S. S., Best, A. M., Wilkinson, D. S., Garrett, C. T., and Ferreira-Gonzalez, A. Genome-wide detection of LOH in prostate cancer using human SNP microarray technology. Genomics, 81: 260-269, 2003.
6. Hoque, M. O., Lee, C. C., Cairns, P., Schoenberg, M., and Sidransky, D. Genome-wide genetic characterization of bladder cancer: a comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis. Cancer Res., 63: 2216-2222, 2003.
7. Primdahl, H., Wikman, F. P., von der Maase, H., Zhou, X. G., Wolf, H., and Orntoft, T. F. Allelic imbalances in human bladder cancer: genome-wide detection with high-density single-nucleotide polymorphism arrays. J. Natl. Cancer Inst. (Bethesda), 94: 216-223. 2002.
8. Singh, D., Febbo, P. G., Ross, K., Jackson, D. G., Manola, J., Ladd, C., Tamayo, P., Renshaw, A. A., D'Amico, A. V., Richie, J. P., Lander, E. S., Loda, M., Kantoff, P. W., Golub, T. R., and Sellers, W. R. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell, 1: 203-209, 2002.
9. Eisen, M. B., Spellman, P. T., Brown, P. O., and Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA, 95: 14863-14868, 1998.
10. Ramaswamy, S., Ross, K. N., Lander, E. S., and Golub, T. R. A molecular signature of metastasis in primary solid tumors. Nat. Genet., 33: 49-54, 2003.
11. Schadt, E. E., Li, C., Ellis, B., and Wong, W. H. Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data. J. Cell. Biochem. Suppl., 37: 120-125, 2001.
12. Li, C., and Hung Wong, W. Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol., 2: 2001.
13. Lundgren, R., Kristoffersson, U., Heim, S., Mandahl, N., and Mitelman, F. Multiple structural chromosome rearrangements, including del(7q) and del(10q), in an adenocarcinoma of the prostate. Cancer Genet. Cytogenet., 35: 103-108, 1988.
14. Carter, B. S., Ewing, C. M., Ward, W. S., Treiger, B. F., Aalders, T. W., Schalken, J. A., Epstein, J. I., and Isaacs, W. B. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc. Natl. Acad. Sci. USA, 87: 8751-8755, 1990.
15. Gray, I. C., Phillips, S. M., Lee, S. J., Neoptolemos, J. P., Weissenbach, J., and Spurr, N. K. Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res., 55: 4800-4803, 1995.
16. Sakr, W. A., Macoska, J. A., Benson, P., Grignon, D. J., Wolman, S. R., Pontes, J. E., and Crissman, J. D. Allelic loss in locally metastatic, multisampled prostate cancer. Cancer Res., 54: 3273-3277, 1994.
17. Matsuyama, H., Pan, Y., Skoog, L., Tribukait, B., Naito, K., Ekman, P., Lichter, P., and Bergerheim, U. S. Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization. Oncogene, 9: 3071-3076, 1994.
18. MacGrogan, D., Levy, A., Bostwick, D., Wagner, M., Wells, D., and Bookstein, R. Loss of chromosome arm 8p loci in prostate cancer: mapping by quantitative allelic imbalance. Genes Chromosomes Cancer, 10: 151-159, 1994.
19. Bova, G. S., Carter, B. S., Bussemakers, M. J., Emi, M., Fujiwara, Y., Kyprianou, N., Jacobs, S. C., Robinson, J. C., Epstein, J. I., Walsh, P. C., et al. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res., 53: 3869-3873, 1993.
20. Nupponen, N. N., Kakkola, L., Koivisto, P., and Visakorpi, T. Genetic alterations in hormone-refractory recurrent prostate carcinomas. Am. J. Pathol., 153: 141-148, 1998.
21. Macoska, J. A., Powell, I. J., Sakr, W., and Lane, M. A. Loss of the 17p chromosomal region in a metastatic carcinoma of the prostate. J. Urol., 147: 1142-1146, 1992.
22. Massenkeil, G., Oberhuber, H., Hailemariam, S., Sulser, T., Diener, P. A., Bannwart, F., Schafer, R., and Schwarte-Waldhoff, I. P53 mutations and loss of heterozygosity on chromosomes 8p, 16q, 17p, and 18q are confined to advanced prostate cancer. Anticancer Res., 14: 2785-2790, 1994.
23. Deubler, D. A., Williams, B. J., Zhu, X. L., Steele, M. R., Rohr, L. R., Jensen, J. C., Stephenson, R. A., Changus, J. E., Miller, G. J., Becich, M. J., and Brothman, A. R. Allelic loss detected on chromosomes 8, 10, and 17 by fluorescence in situ hybridization using single-copy PI probes on isolated nuclei from paraffin-embedded prostate tumors. Am. J. Pathol., 150: 841-850, 1997.
24. Erbersdobler, A., Graefen, M., Wullbrand, A., Hammerer, P., and Henke, R. P. Allelic losses at 8p, 10q, 11p, 13q, 16q, 17p, and 18q in prostatic carcinomas: the impact of zonal location, Gleason grade, and tumour multifocality. Prostate Cancer Prostatic Dis., 2: 204-210, 1999.
25. Elo, J. P., Harkonen, P., Kyllonen, A. P., Lukkarinen, O., Poutanen, M., Vihko, R., and Vihko, P. Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer. Cancer Res., 57: 3356-3359, 1997.
26. Matsuyama, H., Pan, Y., Yoshihiro, S., Kudren, D., Naito, K., Bergerheim, U. S., and Ekman, P. Clinical significance of chromosome 8p, 10q, and 16q deletions in prostate cancer. Prostate, 54: 103-111. 2003.
27. Latil, A., Cussenot, O., Fournier, G., Driouch, K., and Lidereau, R. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions. Cancer Res., 57: 1058-1062, 1997.
28. Abate-Shen, C., and Shen, M. M. Molecular genetics of prostate cancer. Genes Dev., 14: 2410-2434. 2000.